JPMORGAN CHASE & CO

Holdings History for Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

Symbol: AUTL on Nasdaq
Investment type: Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$1,948,757	979,275	+76,207	+8.4%	$1.99	Q4 2025
30 Sep 2025	0%	-0%	$1,472,001	903,068	-11,675	-1.3%	$1.63	Q3 2025
30 Jun 2025	0%	-0%	$2,085,614	914,743	-495,361	-35%	$2.28	Q2 2025
31 Mar 2025	0%	+0%	$2,185,661	1,410,104	+338,571		$1.55	Q1 2025
31 Dec 2024	0%	-0%	$2,518,103	1,071,533	-213,175	-17%	$2.35	Q4 2024
30 Sep 2024	0%	+0%	$4,663,490	1,284,708	+761,008	+145%	$3.63	Q3 2024
30 Jun 2024	0%	+0%	$1,822,476	523,700	+394,791	+306%	$3.48	Q2 2024
31 Mar 2024	0%	+0%	$822,440	128,909	+101,476	+370%	$6.38	Q1 2024
31 Dec 2023	0%	+0%	$176,669	27,433	+27,327	+25780%	$6.44	Q4 2023
30 Sep 2023	0%	0%	$247	106	-1,693	-94%	$2.33	Q3 2023
30 Jun 2023	0%	-0%	$4,282	1,799	-439,226	-100%	$2.38	Q2 2023
31 Mar 2023	0%	-0%	$811,000	441,025	-52,484	-11%	$1.84	Q1 2023
31 Dec 2022	0%	+0%	$938,000	493,509	+50,959	+12%	$1.90	Q4 2022
30 Sep 2022	0%	-0%	$947,000	442,550	-183,969	-29%	$2.14	Q3 2022
30 Jun 2022	0%	-0%	$1,773,000	626,519	-173,039	-22%	$2.83	Q2 2022
31 Mar 2022	0%	-0%	$3,334,000	799,558	-51,986	-6.1%	$4.17	Q1 2022
31 Dec 2021	0%	-0%	$4,419,000	851,544	-499,811	-37%	$5.19	Q4 2021
30 Sep 2021	0%	+0%	$8,851,000	1,351,355	+600,391	+80%	$6.55	Q3 2021
30 Jun 2021	0%	+0%	$4,986,000	750,964	+196,595	+35%	$6.64	Q2 2021
31 Mar 2021	0%	+0%	$3,177,000	554,369	+300,109	+118%	$5.73	Q1 2021
31 Dec 2020	0%	+0%	$2,273,000	254,260	+75,626	+42%	$8.94	Q4 2020
30 Sep 2020	0%	+0%	$2,144,000	178,634	+37,879	+27%	$12.00	Q3 2020
30 Jun 2020	0%	+0%	$2,256,000	140,755	+39,308	+39%	$16.03	Q2 2020
31 Mar 2020	0%	+0%	$608,000	101,447	+63,234	+165%	$5.99	Q1 2020
31 Dec 2019	0%	+0%	$504,000	38,213	+38,213	NEW	$13.19	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.